Published • loading... • Updated
Intero Biosystems wants drugmakers to test on mini human intestines, not animals
Summary by TechCrunch
4 Articles
4 Articles
TechCrunchReposted by 
BizToc
BizTocIntero Biosystems wants drugmakers to test on mini human intestines, not animals
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
·San Francisco, United States
Read Full Article
Intero Biosystems develops human intestinal organoids for pharmaceuticals and other companies to study compounds in laboratory cultured tissue. The startup already sells its GastroScreen model, but recognizes that it is still working to demonstrate whether it can predict human responses more accurately than existing alternatives.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
